Q

Hybrid Global Clinical Study Lead – IVD Oncology

QIAGEN

manchester, england, United-Kingdom Full-time June 29, 2026
Apply Now

Opportunity Description

QIAGEN is seeking a Clinical Study Lead (CSL) to spearhead clinical performance studies for innovative in vitro diagnostic solutions. In this pivotal role, you will work with cross-functional teams and pharmaceutical partners to support regulatory approvals that impact patient outcomes.

The ideal candidate will have an advanced degree in Life Sciences and strong experience with clinical study documentation. You will also be responsible for ensuring compliance with global regulatory frameworks. QIAGEN offers benefits like attractive pensions, private healthcare, and flexible working options.

#J-18808-Ljbffr
Full-time Bio & Pharmacology & Health

Ready to Apply?

Submit your application for Hybrid Global Clinical Study Lead – IVD Oncology at QIAGEN

Apply for this Position